You are here

Article Text

Article menu
Download PDFPDF
Letters to the editor
Comment on ‘Adverse reaction to Nexplanon®’
  1. Diana Mansour, FRCOG, FFSRH
  1. Head of Clinical Service, Sexual Health, Newcastle Hospitals, Community Health, New Croft Centre, Newcastle upon Tyne, UK; diana.mansour@nuth.nhs.uk

https://doi.org/10.1136/jfprhc-2013-100639

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    I would like to thank the Journal for asking me to comment on Dr Chaudhry's letter.1 I lead a regional referral centre for complex contraceptive problems in Newcastle upon Tyne and have managed a small number of women presenting with chronic contraceptive implant infections.

    Published data suggest that post-insertion infections are rare with an incidence of less than 0.5% for …

    View Full Text

    Footnotes

    • Competing interests The author has received financial support to attend pharmaceutical advisory board meetings, undertake research studies, speak at educational meetings and conferences along with travel grants from Astellas, Bayer, Consilient Healthcare, HRA Pharma, Merck, Pfizer and Vifor Pharma.

    • Provenance and peer review Commissioned; internally peer reviewed.